Skip to main content

Nonprofit · EIN 20-0441399

ACTION TO CURE KIDNEY CANCER

Tax-exempt · NEW YORK, NY 10023

Financials

$10K$2K2024$0$3K2025
Revenue Expenses · by fiscal year end
Financials of ACTION TO CURE KIDNEY CANCER by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990-EZ$0$2,565-$2,565$95,138$1,808$93,330
December 31, 2024990-EZ$9,722$1,558$8,164$97,703$1,808$95,895
Financial details: 990-EZ for the year ended December 31, 2025

Revenue

Expenses

Compensation of officers, directors and key employees
$0
Professional fees and payments to contractors
$2,400
Other expenses
$165

Balance sheet and other

Total assets, start of year
$97,703
Total assets, end of year
$95,138
Total liabilities, end of year
$1,808
Net assets, end of year
$93,330
Cash, savings and investments
$95,138
Gross receipts
$0

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
JAY BITKOWERPRESIDENT5$0
PATRICIA TODDTREASURER2$0
990-EZ for the year ended December 31, 2024: 2 people
NameTitleHours / weekCompensation
JAY BITKOWERPRESIDENT5$0
PATRICIA TODDTREASURER2$0

Address and contacts

Address (IRS master file)
165 WEST END AVE APT 14AB, NEW YORK, NY 10023-5503
In care of
% JAY BITKOWER
Mailing address (990-N for 2023)
165 WEST END AVE APT 14AB, NEW YORK NY 100235503
Principal officer (990-N for 2023)
JAY BITKOWER, 165 WEST END AVE APT 14AB, NEW YORK NY 100235503
Signed the 990-EZ
JAY BITKOWER, PRESIDENT
Phone
(212) 799-4354
Return prepared by
JTS ASSOCIATES CPAS PC

Mission

ACKC WAS FOUNDED IN ORDER TO EDUCATE THE KIDNEY CANCER PATIENTS, CAREGIVERS AND THE GENERAL PUBLIC ABOUT THE DISEASE; INCREASE FEDERAL FUNDING FOR CANCER RESEARCH; GIVE MODEST GRANTS TO PROMISING YOUNG INVESTIGATORS; PUBLICIZE THE CAUSES AND PREVENTIONS OF KIDNEY CANCER; NEGOTIATE WITH DRUG COMPANIES WITH RESPECT TO TESTING THEIR PRODUCTS IN KIDNEY CANCER PATIENTS.ACKC MOSTLY FUNDS GRANTS WHOSE RESEARCH BIG PHARMA DOES NOT FIND PROFITABLE AND, OVER THE YEARS, WE'VE ISSUED GRANTS IN THE AMOUNT OF $400,000 TO KIDNEY CANCER INVESTIGATORS. WE CONCENTRATE ON RAISING THE AWARENESS OF CAUSES SUCH AS PFAS CHEMICALS,AND PROMOTE EARLY DETECTION AND LIFESTYLE CHANGES SINCE WHEN KIDNEY CANCER IS DISCOVERED AT AN EARLY STAGE, THE SURVIVAL POTENTIAL IS HIGHER.FINALLY, WE LOBBY CONGRESS TO APPROPRIATE RESEARCH MONEY FOR KIDNEY CANCER. IN 2006, WERE SUCCESSFUL IN HAVING CONGRESS INCLUDE KIDNEY CANCER IN THE DEPARTMENT OF DEFENSE'S PEER REVIEW CANCER RESEARCH

990-EZ for the year ended December 31, 2025

Program accomplishments

  • KIDNEY CANCER RESEARCH

What it must file and when

IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990-EZ on file
2024December 31, 2024May 15, 2025990-EZ on file
2023December 31, 2023May 15, 2024990-N on file

IRS record

EIN
20-0441399
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2004
Accounting year ends
December
Files
Form 990-N (e-Postcard)
Category (NTEE)
Medical research (H12)
Assets (IRS master file)
$95,138

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2025$0$2,565$95,138IRS
990-EZDecember 2024$9,722$1,558$97,703IRS
990-N for 2023
Officer: JAY BITKOWER
December 31, 2023≤ $50,000 receipts––e-Postcard
990-N for 2022
Officer: JAY BITKOWER
December 31, 2022≤ $50,000 receipts––e-Postcard
990-EZDecember 2022–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-0441399).

Questions about ACTION TO CURE KIDNEY CANCER

What is the EIN of ACTION TO CURE KIDNEY CANCER?
The employer identification number (EIN) of ACTION TO CURE KIDNEY CANCER is 20-0441399.
Is ACTION TO CURE KIDNEY CANCER tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2004.
Are donations to ACTION TO CURE KIDNEY CANCER tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does ACTION TO CURE KIDNEY CANCER file?
Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
When is the next return of ACTION TO CURE KIDNEY CANCER due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did ACTION TO CURE KIDNEY CANCER last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2025.
Who is the principal officer of ACTION TO CURE KIDNEY CANCER?
The 990-N for 2023 names JAY BITKOWER.
Who are the officers and directors of ACTION TO CURE KIDNEY CANCER?
The 990-EZ for the year ended December 31, 2025 lists 2 people; 0 received compensation from the organization.
How much revenue does ACTION TO CURE KIDNEY CANCER have?
On its 990-EZ for the year ended December 31, 2025 it reported revenue of $0, expenses of $2,565 and total assets of $95,138 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Medical research